Compare CSW & TMDX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | CSW | TMDX |
|---|---|---|
| Founded | 2014 | 1998 |
| Country | United States | United States |
| Employees | 2600 | N/A |
| Industry | Home Furnishings | Biotechnology: Electromedical & Electrotherapeutic Apparatus |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 4.2B | 3.4B |
| IPO Year | N/A | 2019 |
| Metric | CSW | TMDX |
|---|---|---|
| Price | $284.33 | $116.47 |
| Analyst Decision | Hold | Buy |
| Analyst Count | 5 | 9 |
| Target Price | ★ $321.40 | $148.22 |
| AVG Volume (30 Days) | 120.7K | ★ 943.6K |
| Earning Date | 05-21-2026 | 05-07-2026 |
| Dividend Yield | ★ 0.35% | N/A |
| EPS Growth | N/A | ★ 382.18 |
| EPS | N/A | ★ 4.87 |
| Revenue | N/A | ★ $605,494,000.00 |
| Revenue This Year | $23.19 | $24.51 |
| Revenue Next Year | $18.95 | $18.72 |
| P/E Ratio | $40.25 | ★ $23.78 |
| Revenue Growth | N/A | ★ 37.13 |
| 52 Week Low | $230.45 | $84.53 |
| 52 Week High | $337.02 | $156.00 |
| Indicator | CSW | TMDX |
|---|---|---|
| Relative Strength Index (RSI) | 54.74 | 53.49 |
| Support Level | $284.40 | $109.43 |
| Resistance Level | $333.30 | $120.28 |
| Average True Range (ATR) | 11.55 | 4.85 |
| MACD | 4.76 | 2.54 |
| Stochastic Oscillator | 56.00 | 94.75 |
CSW Industrials Inc is a diversified industrial growth company with well-established, scalable platforms and domain expertise across three segments, Contractor Solutions, Engineered Building Solutions, and Specialized Reliability Solutions. The company's Contractor Solutions segment involves manufacturing efficient and performance-enhancing products for residential and commercial HVAC/R and plumbing applications, which are designed for professional end-use customers. Majority of the company revenue is generated from Contractor Solutions segment from U.S. markets.
TransMedics Group Inc is a commercial-stage medical technology company transforming organ transplant therapy for end-stage organ failure patients across multiple disease states. It has developed the Organ Care System (OCS) to comprehensively address the limitations of cold storage. The OCS is a portable organ perfusion, optimization, and monitoring system that utilizes technology to replicate near-physiologic conditions for donor organs outside of the human body. The company has developed and is commercializing a proprietary system to preserve and deliver human organs for transplant in a near-physiologic condition to address the limitations of cold storage organ preservation.